¶óÆæÆ®¦¢Ä«Æä¦¢ºí·Î±×¦¢´õº¸±â
¾ÆÄ«µ¥¹Ì Ȩ ¸í»çƯ°­ ´ëÇבּ¸½Ç޹æ Á¶°æ½Ç¹« µ¿¿µ»ó°­ÀÇ Çѱ¹ÀÇ ÀüÅëÁ¤¿ø ÇÐȸº° ³í¹®
ÇÐȸº° ³í¹®

Çѱ¹°Ç¼³°ü¸®ÇÐȸ
Çѱ¹°ÇÃà½Ã°øÇÐȸ
Çѱ¹µµ·ÎÇÐȸ
Çѱ¹»ý¹°È¯°æÁ¶ÀýÇÐȸ
Çѱ¹»ýÅÂÇÐȸ
Çѱ¹¼öÀÚ¿øÇÐȸ
Çѱ¹½Ä¹°ÇÐȸ
Çѱ¹½Ç³»µðÀÚÀÎÇÐȸ
Çѱ¹ÀÚ¿ø½Ä¹°ÇÐȸ
Çѱ¹ÀܵðÇÐȸ
Çѱ¹Á¶°æÇÐȸ
Çѱ¹Áö¹Ý°øÇÐȸ
Çѱ¹ÇÏõȣ¼öÇÐȸ
Çѱ¹È¯°æ»ý¹°ÇÐȸ
Çѱ¹È¯°æ»ýÅÂÇÐȸ

Çѱ¹ÇÏõȣ¼öÇÐȸ / v.38, no.1, 2005³â, pp.11-17
³»ºÐºñ±³¶õ ¹°Áú¿¡ ³ëÃâµÈ C. plumosus (Àå¼ö±òµû±¸)ÀÇ Çϼø±âÀý ±âÇü¼º
( The Mentum Deformity of C. plumosus Following Exposure to Endocrine Disruption Chemicals )
ÀÌ¿øÃ¶;°ûÀνÇ; ÇѾç´ëÇб³ ÀÚ¿¬°úÇдëÇÐ »ý¸í°úÇаú;ÇѾç´ëÇб³ ÀÚ¿¬°úÇдëÇÐ »ý¸í°úÇаú;
 
ÃÊ ·Ï
¾ß¿Ü¿¡¼­ äÁýÇÑ C. plumosus¸¦ ´ë»óÀ¸·Î ÀáÀçÀû ³» ºÐºñ°è ±³¶õ¹°ÁúÀÎ DEHP, BPA ¹× Tebufenozide¸¦ 󸮹°Áú·Î ÇÏ¿© ÇüÅÂÀûÀÎ ±³¶õ È¿°ú¸¦ »ìÆìº¸¾Ò´Ù. ¾àÁ¦¿¡ ³ëÃâµÈ °³Ã¼ÀÇ Çϼø±âÀýÀº ºÎµå·¯¿öÁö°Å³ª(smooth) ¼Õ½Ç(loss)ÀÌ °¡Àå ¸¹¾ÒÀ¸¸ç ¿¯Àº °¥»öÀ» º¸¿´´Ù. ó¸® ¹°Áú¿¡ µû¸¥ ±âÇüÀÇ Á¤µµ¸¦ »ìÆìº¸¸é, DEHP´Â 46.2 ${sim}$ 85.7%, BPA´Â 73.7 ${sim}$ 90.9% ±×¸®°í tebufenozide´Â 57.6 ${sim}$ 78.9%°¡ ±âÇüÀ» ÀÔ¾î BPA>tebufenozide>DEHP ¼øÀ¸·Î ±âÇüÀÌ Å©°Ô ³ªÅ¸³µ´Ù. ó¸® ¹°Áúº° ±âÇü ºÎÀ§¸¦ »ìÆìº¸¸é, MIX (32 ${sim}$ 46%)>MLT (25 ${sim}$ 34%)>LT (3 ${sim}$ 7%)·Î µÎ ºÎºÐÀÌ ÇÔ²² ±âÇüÀ» ÀÔ´Â ÇüŰ¡ °¡Àå ¸¹¾ÒÀ¸¸ç LT ´Üµ¶ÀÇ ±âÇüÀÌ °¡Àå Àû¾ú´Ù. MIX ÇüÅ·Π±âÇüÀÌ °¡Àå ³ôÀº ¹°ÁúÀº BPA (46%)>DEHP (33%)>tebufenozide (32%)À̰í, MLT¿¡ °¡Àå ³ôÀº ±âÇüÀ» º¸ÀÎ °ÍÀº DEHP (34%)>tebufenozide (31%)>BPA (25%)·Î ³ªÅ¸³µ´Ù. Tebufenozide 󸮿¡ µû¸¥ Çϼø±âÀýÀÇ »öÀº ó¸® ³óµµ°¡ ³ô¾ÆÁö¸é ¿¯Àº °¥»ö Çϼø±âÀýÀÇ ¹ß»ý ºóµµ°¡ Áõ°¡µÇ¾ú´Ù (27.8 ${sim}$ 84.2%). ¹Ý¸é, BPA (8.7%)¿Í DEHP (18.2%)´Â $1;{mu}g;L^{-1}$¿¡¼­ °¡Àå ³·Àº ¿¯Àº °¥»öÀÇ Çϼø±âÀýÀÇ ¹ß»ý ºóµµ¸¦ º¸¿´À¸³ª $0.3;{mu}g;L^{-1}$󸮿¡¼­´Â ¸Å¿ì ³ôÀº ¿¯Àº °¥»öÀÇ Çϼø±âÀýÀÌ ´Ù¼ö ¹ß»ýÇÏ¿´´Ù (BPA 52.6%; DEHP 30.8%).
Egg masses of C. plumosus were collected from Jungnang Stream in Seoul and reared in an incubator chamber. The larvae of C. plumosus were treated with potential endocrine disruption chemicals (EDCs) such as Diethylhexyl phthalate (DEHP), Bisphenol A (BPA) and Tebufenozide, and the effects of morphological abnormalities were observed. The deformities of the mentum following exposure to EDCs showed the smooth/round tooth, the loss of ${ge}$1 tooth, reduced median lateral teeth (MLT) and light brown color. The incidence rates of the mentum deformity were associated with chemicals: BPA (73.7 ${sim}$ 90.9%)>tebufenozide (57.6 ${sim}$ 78.9%)>DEHP (46.2 ${sim}$ 85.7%). The deformity type of the mentum showed MIX (MLT+LT, 32 ${sim}$ 46%)>MLT (25 ${sim}$ 34%)>LT (lateral teeth, 3 ${sim}$ 7%). Also, the incidence of MIX type was in the order of BPA (46%)>DEHP (33%) >tebufenozide (32%), and that of MLT type showed DEHP (34%)>tebufenozide (31%)>BPA (25%). As the concentration of Tebufenozide increased, the incidence of light brown mentum was dose dependent. While the incidences of light brown mentum following exposure to BPA and DEHP were not associated with their concentrations.
 
Ű¿öµå
diethylhexyl phthalate;bisphenol A;tobufenozide;C. plumosus;mentum deformity;
 
Çѱ¹ÇÏõȣ¼öÇÐȸÁö / v.38, no.1, 2005³â, pp.11-17
Çѱ¹ÇÏõȣ¼öÇÐȸ
ISSN : 1976-8087
UCI : G100:I100-KOI(KISTI1.1003/JNL.JAKO200518317183916)
¾ð¾î : Çѱ¹¾î
³í¹® Á¦°ø : KISTI Çѱ¹°úÇбâ¼úÁ¤º¸¿¬±¸¿ø
¸ñ·Ïº¸±â
ȸ»ç¼Ò°³ ±¤°í¾È³» ÀÌ¿ë¾à°ü °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ Ã¥ÀÓÀÇ ÇѰè¿Í ¹ýÀû°íÁö À̸ÞÀÏÁÖ¼Ò ¹«´Ü¼öÁý °ÅºÎ °í°´¼¾ÅÍ
   

ÇÏÀ§¹è³ÊÀ̵¿